| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1055 | Bms-250685 | Selective ATP hydrolase inhibitor |
|
| DCC1056 | Bms-262084 | Potent and selective beta-lactam tryptase inhibitor, inhibiting factor XIa and producing antithrombotic efficacy with minimal bleeding time prolongation |
|
| DCC1057 | Bms-281384 | Highly potent and selective phosphodiesterase 5 (PDE 5) inhibitor |
|
| DCC1058 | Bms-286309 | Novel fluoro-substituted camptothecin, inducing topoisomerase I-mediated DNA breaks |
|
| DCC1059 | Bms-341 | Novel dissociated glucocorticoid receptor modulator |
|
| DCC1060 | Bms-351 | Novel Selective CYP17A1 Lyase Inhibitor |
|
| DCC1061 | Bms-422461 | Prodrug of the novel fluoro-substituted camptothecin analog, BMS-286309 |
|
| DCC1062 | Bms-488043 | Novel Inhibitor of human immunodeficiency virus type 1 (HIV-1) attachment |
|
| DCC1063 | Bms-538305 Tartrate | Potent and selective dipeptidyl peptidase IV (DPP-IV) inhibitor |
|
| DCC1064 | Bms-566394 | Novel, potent, exceptionally selective inhibitor of TNF-α Converting Enzyme (TACE) |
|
| DCC1065 | Bms-585248 | Novel Inhibitor of human immunodeficiency virus type 1 (HIV-1) attachment |
|
| DCC1066 | Bms-665053 | Novel potent antagonist of corticotropin-releasing factor/hormone receptor 1 (CRHR-1) |
|
| DCC1067 | Bms-698861 | Novel Novel γ-secretase modulator, decreasing Aß1-40 and Aß1-42 and increasing Aß1-37 and Aß1-38 in rat brain modulator, decreasing Aß1-40 and Aß1-42 and increasing Aß1-37 and Aß1-38 in rat brain |
|
| DCC1068 | Bms-763534 | Novel potent antagonist of corticotropin-releasing factor/hormone receptor 1 (CRHR-1) |
|
| DCC1069 | Bms-764459 | Novel potent antagonist of corticotropin-releasing factor/hormone receptor 1 (CRHR-1) |
|
| DCC1070 | Bms-821095 | Potent, Orally Bioavailable, Metabolically Stable Thumb Site 1 Inhibitor of the Hepatitis C Virus NS5B RNA-Dependent, RNA Polymerase |
|
| DCC1071 | Bms-870145 | Novel potent and selective P2Y1 purinergic receptor antagonist. |
|
| DCC1072 | Bms-883559 | Novel inhibitor of the influenza nucleoprotein (INF-NP) |
|
| DCC1073 | Bms-902483 | Potent alpha7 Nicotinic receptor partial agonist, improving cognition in preclinical rodent model |
|
| DCC1074 | Bms-903452 | Potent and selective GPR119 agonist |
|
| DCC1075 | Bms-960 | Novel Agonist of Sphingosine-1-Phosphate (S1P1) |
|
| DCC1076 | Bms-961 | Selective RARγ agonist |
|
| DCC1077 | Bms-986034 | Novel GPR119 agonist |
|
| DCC1078 | Bms-986104 | Novel S1P1 receptor modulator |
|
| DCC1079 | Bms-986133 | Novel γ-secretase modulator |
|
| DCC1080 | Bms-986139 | Novel pan-genotype inhibitor of HCV NS5B polymerase via binding to the primer grip site |
|
| DCC1081 | Bmsg-sh-3 | G-quadruplex ligand, decreasing oncogene expression |
|
| DCC1082 | Bmv109 | Novel fluorescent activity-based probe (ABP), being intrinsically dark and only emitting fluorescence after reaction with the target protease, are ideally suited for imaging techniques such as small animal noninvasive fluorescence imaging and live cell fl |
|
| DCC1083 | Bmy-25368 | Potent long-acting H2-receptor antagonist |
|
| DCC1084 | Bnm-iv-147 | Novel CD4 mimic, inhibiting HIV-1 entry into target cells with both significantly higher potency and neutralization breadth than previous congeners, while maintaining high selectivity for the target virus |
|
